Clinical trial

n-3 Polyunsaturated Fatty Acids in Obesity

NCT00760760

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-09-01

PhasePHASE2

Study timeline

Study start (unknown)2008-09-01Date precision: month

Registry last updated2016-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adipose Tissue Inflammationunresolved

Morbid Obesityverified · MONDO: morbid obesity

Interventions

reesterified long-chain n-3 polyunsaturated fatty acids (EPA, DHA)DRUG

controlDRUG

Sponsors & collaborators

Medical University of Viennalead sponsor

National Bank of Austriacollaborator

Mapped research locations

ViennaAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00760760 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.